Literature DB >> 14233152

HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.

M M BEST, C H DUNCAN.   

Abstract

Entities:  

Keywords:  ADRENALECTOMY; ANDROSTERONE; ANTICHOLESTEREMIC AGENTS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BUTYRATES; CASTRATION; CHOLESTEROL; EXPERIMENTAL LAB STUDY; GLYCERIDES; HEPATOMEGALY; LIPID METABOLISM; LIPOIDOSIS; LIVER; LIVER DISEASES; PHARMACOLOGY; RATS; THIOURACIL; THYROIDECTOMY; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14233152

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  18 in total

1.  Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

Authors:  M A D'Costa; A Angel
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

2.  Effects of clofibrate on some microsomal hydroxylations involved in the formation and metabolism of bile acids in rat liver.

Authors:  B O Angelin; I Björkhem; K Einarsson
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

Review 3.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

4.  Clofibrate and fat embolism.

Authors:  J C McPherson; W S Harms; L T Ellison; R G Ellison
Journal:  Br Med J       Date:  1972-08-19

5.  Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.

Authors:  K Kutz; A Schulte; C Just; H Lindstaedt; B Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

6.  Biosynthesis of pyrimidine nucleotides and level of cytochrome P-450 in rat liver and kidney after clofibrate administration (an in vivo study).

Authors:  J Seifert; Z Machková
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Effects of clofibrate on the metabolism of progesterone and oestradiol in rat liver microsomal fraction.

Authors:  K Einarsson; J A Gustafsson; K Hellström
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

8.  Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.

Authors:  T Watanabe; N D Lalwani; J K Reddy
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

9.  Inhibition of hepatic triglyceride formation by clofibrate.

Authors:  L L Adams; W W Webb; H J Fallon
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

10.  Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.

Authors:  M O'Brien; S T Patel; A Mukhopadhyay; H A Newman; D R Feller; S S Kokrady; D T Witiak; R R Lanese; J C Rice
Journal:  Lipids       Date:  1981-12       Impact factor: 1.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.